Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Imaging BiometricsIQAIF EV-to-EBIT is -10.33 as of Aug. 26, 2026. The stock has 4 warning signs investors should review. Among 479 Healthcare Providers & Services companies, Imaging Biometrics ranks worse than 208768.06% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Imaging Biometrics's Enterprise Value for the quarter that ended in Jun. 2026 was $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Imaging Biometrics's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imaging Biometrics EV-to-EBIT Related Terms
Imaging Biometrics EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Imaging Biometrics's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Imaging Biometrics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imaging Biometrics EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Imaging Biometrics's EV-to-EBIT falls into.
Imaging Biometrics's current Enterprise Value is $3.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Imaging Biometrics's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imaging Biometrics (IQAIF) has a EV-to-EBIT of -10.33 as of Aug. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Imaging Biometrics and its competitors. According to the industry distribution chart, Imaging Biometrics ranks #999999 out of 479 companies in the Healthcare Providers & Services industry.
Is Imaging Biometrics' EV-to-EBIT too high?
Imaging Biometrics' current EV-to-EBIT is -10.33. Based on the distribution chart, Imaging Biometrics ranks #999999 out of 479 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Imaging Biometrics' EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #999999 out of 479 companies for EV-to-EBIT. This places Imaging Biometrics in the lower half of its industry. The industry median EV-to-EBIT is 15.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.70, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current EV-to-EBIT is -10.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current EV-to-EBIT of -10.33. The current EV-to-EBIT is -10.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current EV-to-EBIT is -10.33 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQAIF has been successfully added to your 
